Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Short Interest Up 144.0% in December

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) was the target of a large increase in short interest in December. As of December 31st, there was short interest totalling 12,200 shares, an increase of 144.0% from the December 15th total of 5,000 shares. Based on an average daily volume of 5,300 shares, the short-interest ratio is currently 2.3 days.

Clinuvel Pharmaceuticals Stock Up 1.6 %

OTCMKTS:CLVLY traded up $0.12 during mid-day trading on Thursday, reaching $7.39. The stock had a trading volume of 1,429 shares, compared to its average volume of 6,161. Clinuvel Pharmaceuticals has a 1-year low of $6.80 and a 1-year high of $11.40. The stock’s 50 day simple moving average is $8.10 and its two-hundred day simple moving average is $9.13.

Clinuvel Pharmaceuticals Company Profile

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).